Sabaa Pharmaceutical's shareholders approve capital raise via bonus issue
Sabaa Pharmaceutical's profit leaps 76% in 2020 initial results
WHO ‘strongly’ against hydroxychloroquine use for COVID-19 prevention
We venture to make the world a healthier place, where the right to medicine is never denied.
© 2021 - 2022 All Rights Reserved. Designed & Developed By Spark Systems